Emmanuelle Charpentier Nobel prize laureate in Chemistry, and the founder of the CRISPR-Cas9 gene editing technology explains how she got the idea and why she went to Umeå University and MIMS Laboratory in Sweden. She also talks about how important external funding, like grants from Knut and Alice Wallenberg Foundation, are for excellent ground-breaking research.
Producerad av Dramasvecia